GB1379533A — O-substituted oxime derivatives of hydroxyphthalaldehydic acids methods for their preparation and compositions containing them
Assigned to ENDO LAB · Expires 1975-01-02 · 51y expired
What this patent protects
1379533 Oximes of phthalaldehydic acid derivatives ENDO LABORATORIES Inc 29 May 1973 [30 May 1972 19 April 1973] 25464/73 Heading C2C Novel compounds I in which R is hydrogen or acetyl, R<SP>1</SP> is phenyl, morpholino or phenyl substituted by one or two substituents…
USPTO Abstract
1379533 Oximes of phthalaldehydic acid derivatives ENDO LABORATORIES Inc 29 May 1973 [30 May 1972 19 April 1973] 25464/73 Heading C2C Novel compounds I in which R is hydrogen or acetyl, R<SP>1</SP> is phenyl, morpholino or phenyl substituted by one or two substituents selected from chlorine, bromine, fluorine, trifluoromethyl, nitro, methoxy or ethoxy and " alk " is alkylene of 1 to 3 C atoms with the proviso that when R<SP>1</SP> is morpholino, " alk " is ethylene or propylene and their salts are prepared by reacting a compound II with an O-substituted hydroxylamine to form a compound I in which R is hydrogen and if desired, acylating this to introduce the acetyl group. Compounds I are analgesic, anti-inflammatory and immuno-suppressant agents and form with a carrier a pharmaceutical composition which may be administered orally, or parenterally.
Drugs covered by this patent
- Mayzent (SIPONIMOD) · Novartis
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.